This summary was created by AI, based on 1 opinions in the last 12 months.
Based on the reviews from different experts, it can be concluded that iShares S&P Global Healthcare (XHC-T) is the No. 1 market-cap weighted stock in the healthcare sector with a relatively low MER of 0.66%. The company seems to be well-positioned to benefit from the growth in the global healthcare industry. With a strong focus on healthcare, it offers a diversified investment option for those looking to capitalize on the sector's potential. Overall, the reviews indicate that iShares S&P Global Healthcare is a promising investment in the healthcare segment.
(A Top Pick May 29/19, Up 4%) He prefers owning a basket of diversified, global healthcare stocks, not just Canada. XHC is hedged, so there's no currency risk. He owns it for these two reasons.
Pullback due to concerns the democratic left will win the election is actually an opportunity to come back into healthcare. Healthcare is always a long-term play. Yield is 1.6%.
They like the Canadian hedging. He can play healthcare this way and not take on the product risk. It broke out earlier in the year and now is breaking out again.
Healthcare ETF. Playing the global healthcare space. BMO has one with a currency hedge on it. Thinks Healthcare will be a good bet for the next 20-30 years. You have to look at what is in them. Pharma vs. Biotech are different stories. This one is mostly large Pharma, which has its challenges. Should be bought about $30 where there is good support.
This whole healthcare space is something that you want to own. He owns the iShares US healthcare (IYH-N) which owns all the large US healthcare names. Continues to move along at a very nice clip.
This is a global basket of health care stocks. Chart shows a little bit of a correction that took place in the early part of the year. Had a strong run at the beginning of the year which is very unusual for healthcare. There has been a pull back which is fine because it did so well earlier on. It is now getting back close to the top. We are into the seasonal period for healthcare, which is in August. We are just a few weeks away from that so this is an attractive sector.
There is no top in sight for this one. It just works higher. Anything related to this space has legs.
Health Care Sector. Likes it in general, long term. It will have volatility. If we get a correction, wait for it to come to $25. A nice stable place to get a yield from.
Doesn’t know this one specifically but for healthcare, there are a couple of them such as BMO EqWt US HthCare Hedged CAD (ZUH-T) and iShares Global Healthcare (IXJ-N). Global ones tend to be big Pharma and usually a little bit of biotech.
Canadian Dollar Hedged. Has not looked at it but does not think there is a problem with it. He'd like to look at.
iShares S&P Global Healthcare is a Canadian stock, trading under the symbol XHC-T on the Toronto Stock Exchange (XHC-CT). It is usually referred to as TSX:XHC or XHC-T
In the last year, 1 stock analyst published opinions about XHC-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for iShares S&P Global Healthcare.
iShares S&P Global Healthcare was recommended as a Top Pick by on . Read the latest stock experts ratings for iShares S&P Global Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered iShares S&P Global Healthcare In the last year. It is a trending stock that is worth watching.
On 2024-11-22, iShares S&P Global Healthcare (XHC-T) stock closed at a price of $70.58.
Market-cap weighted. MER is 0.66%.